• Antiangiogenic strategies in hepatocellular carcinoma: current status 

      Zacharoulis, D.; Hatzitheofilou, C.; Athanasiou, E.; Zacharoulis, S. (2005)
      Hepatocellular carcinoma is a leading cause of cancer death worldwide in both adult and pediatric patients. Despite many options, no ideal treatment exists for this highly malignant tumor, and management strategies have ...
    • In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG) 

      Mitsogiannis, I. C.; Psaroudaki, Z.; Perrea, D.; Paniara, O.; Melekos, M. D.; Zervas, A.; Mitropoulos, D. (2006)
      Background: Mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG) intravesical instillations are widely and effectively used as adjuvant treatment for superficial bladder cancer. In an attempt to improve the efficacy of ...
    • Occult hepatitis B virus infection in patients with autoimmune liver diseases 

      Georgiadou, S. P.; Zachou, K.; Liaskos, C.; Gabeta, S.; Rigopoulou, E. I.; Dalekos, G. N. (2009)
      Occult hepatitis B virus (HBV) infection is characterized by undetectable serum HBV surface antigen (HBsAg) but detectable HBV-DNA in serum or liver. To determine the prevalence and clinical impact of occult HBV in autoimmune ...